Income Statement FMC Corporation

Stocks

FMC

US3024913036

Agricultural Chemicals

Market Closed - NYSE Other stock markets 21:00:03 14/07/2026 BST			After hours 00:55:05
10.72 ^USD	-1.74%		10.72	+0.05%

07-08	FMC Files First Global Regulatory Submission for Rimisoxafen to US EPA	MT
07-08	FMC Corporation Submits Regulatory Dossier for Rimisoxafen to United States Environmental Protection Agency	CI

c2c6a57e2307ecbced05.c6aH2yTXBfBUbZO3BpFctHK6RAXAHwQJZX_AvVbQp5s.EOLL7xKddro9VL7lP9QkxT7QG3CSaWtiUh2R7B6i8exGke2jELk8xTgkyg

Published financial data: FMC CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	5.05B	5.8B	4.49B	4.25B	3.47B
Total Revenues	5.05B	5.8B	4.49B	4.25B	3.47B
Cost of Goods Sold, Total	2.87B	3.48B	2.66B	2.6B	2.3B
Gross Profit	2.17B	2.33B	1.83B	1.65B	1.17B
Selling General & Admin Expenses, Total	714M	775M	734M	645M	659M
R&D Expenses	305M	314M	329M	278M	266M
Other Operating Expenses	-	-	88.7M	91.2M	7.1M
Other Operating Expenses, Total	1.02B	1.09B	1.15B	1.01B	932M
Operating Income	1.15B	1.24B	679M	635M	240M
Interest Expense, Total	-131M	-152M	-237M	-236M	-240M
Interest And Investment Income	-	-	-	-	-
Net Interest Expenses	-131M	-152M	-237M	-236M	-240M
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	-	-	-75.2M	-	-
EBT, Excl. Unusual Items	1.02B	1.09B	367M	399M	600K
Restructuring Charges	-24.4M	26.1M	-48.4M	-303M	-1.78B
Merger & Related Restructuring Charges	-17.1M	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-	-	-	174M	-
Asset Writedown	-	-	-	-	-195M
Legal Settlements	-	-	-	-	-
Other Unusual Items	-86.9M	-128M	-18.2M	-18.2M	83.3M
EBT, Incl. Unusual Items	894M	984M	300M	252M	-1.89B
Income Tax Expense	91.6M	145M	-1.12B	-151M	314M
Earnings From Continuing Operations	802M	839M	1.42B	403M	-2.2B
Earnings Of Discontinued Operations	-68.2M	-97.2M	-98.5M	-61.8M	-36.6M
Net Income to Company	734M	742M	1.32B	342M	-2.24B
Minority Interest	2.5M	-5M	500K	-500K	-1.5M
Net Income - (IS)	736M	736M	1.32B	341M	-2.24B
Preferred Dividend and Other Adjustments	1.8M	1.7M	2.7M	1.2M	1.1M
Net Income to Common Incl Extra Items	735M	735M	1.32B	340M	-2.24B
Net Income to Common Excl. Extra Items	803M	832M	1.42B	402M	-2.2B
Per Share Items
Net EPS - Basic	5.72	5.83	10.55	2.72	-17.9
Basic EPS - Continuing Operations	6.25	6.6	11.33	3.21	-17.6
Basic Weighted Average Shares Outstanding	128M	126M	125M	125M	125M
Net EPS - Diluted	5.7	5.8	10.51	2.71	-17.9
Diluted EPS - Continuing Operations	6.23	6.57	11.29	3.2	-17.6
Diluted Weighted Average Shares Outstanding	129M	127M	126M	125M	125M
Normalized Basic EPS	5	5.35	1.84	1.99	-0.01
Normalized Diluted EPS	4.97	5.32	1.83	1.99	-0.01
Dividend Per Share	1.97	2.17	2.32	2.32	1.82
Payout Ratio	33.56	36.32	21.98	85.19	-13.01
Supplemental Items
EBITDA	1.32B	1.41B	864M	811M	414M
EBITA	1.22B	1.3B	744M	701M	313M
EBIT	1.15B	1.24B	679M	635M	240M
EBITDAR	1.36B	1.45B	910M	860M	458M
Effective Tax Rate - (Ratio)	10.25	14.76	-372.85	-59.76	-16.65
Current Domestic Taxes	-14.7M	45.8M	59.6M	29.2M	4M
Current Foreign Taxes	96.6M	152M	114M	160M	5.4M
Total Current Taxes	81.9M	198M	174M	189M	9.4M
Deferred Domestic Taxes	16.8M	-25.3M	-80.8M	-68.4M	9.5M
Deferred Foreign Taxes	-7.1M	-27.4M	-1.21B	-272M	295M
Total Deferred Taxes	9.7M	-52.7M	-1.29B	-340M	305M
Normalized Net Income	641M	674M	230M	249M	-1.12M
Interest Capitalized	3.4M	5.6M	9.3M	9.6M	12M
Non-Cash Pension Expense	20.7M	9.3M	18.7M	18.9M	13.7M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	305M	314M	329M	278M	266M
Net Rental Expense, Total	38.6M	39.2M	46.5M	48.7M	44.5M
Imputed Operating Lease Interest Expense	12.25M	14.6M	24.36M	25.16M	23.28M
Imputed Operating Lease Depreciation	26.35M	24.6M	22.14M	23.54M	21.22M
Stock-Based Comp., SG&A Exp. (Total)	17.8M	24.2M	25.9M	23.8M	24M
Total Stock-Based Compensation	17.8M	24.2M	25.9M	23.8M	24M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	517M	572M	302M	357M	584M
Trading Asset Securities, Total	3.7M	12.4M	-	-	-
Total Cash And Short Term Investments	520M	584M	302M	357M	584M
Accounts Receivable, Total	2.58B	2.87B	2.7B	2.9B	2.06B
Other Receivables	228M	176M	243M	263M	302M
Total Receivables	2.81B	3.05B	2.95B	3.17B	2.36B
Inventory	1.41B	1.65B	1.72B	1.2B	1.22B
Prepaid Expenses	140M	118M	95.8M	72.8M	94.7M
Other Current Assets, Total	59.1M	37.6M	59.7M	160M	696M
Total Current Assets	4.94B	5.44B	5.13B	4.96B	4.96B
Gross Property Plant And Equipment	1.46B	1.54B	1.68B	1.71B	1.71B
Accumulated Depreciation	-512M	-566M	-667M	-748M	-895M
Net Property Plant And Equipment	952M	973M	1.01B	960M	812M
Long-term Investments	9.2M	14.5M	19.8M	25.6M	20.4M
Goodwill	1.46B	1.59B	1.59B	1.51B	-
Other Intangibles, Total	2.67B	2.64B	2.59B	2.47B	2.46B
Accounts Receivable Long-Term	57.4M	60.8M	19.5M	39.7M	75.1M
Deferred Tax Assets Long-Term	218M	211M	1.34B	1.52B	1.22B
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	277M	243M	225M	166M	148M
Total Assets	10.58B	11.17B	11.93B	11.65B	9.69B
Liabilities
Accounts Payable, Total	1.14B	1.25B	602M	768M	771M
Accrued Expenses, Total	846M	939M	1.01B	1.08B	873M
Short-term Borrowings	356M	452M	838M	261M	720M
Current Portion of Long-Term Debt	84.5M	88.5M	96.5M	76.1M	586M
Current Portion of Leases	23.5M	22M	24.4M	24.5M	26.3M
Current Income Taxes Payable	65.4M	115M	124M	122M	24M
Unearned Revenue Current, Total	631M	680M	482M	454M	453M
Other Current Liabilities	379M	250M	206M	233M	302M
Total Current Liabilities	3.52B	3.8B	3.38B	3.02B	3.76B
Long-Term Debt	2.73B	2.73B	3.02B	3.03B	2.77B
Long-Term Leases	140M	129M	123M	106M	97.6M
Pension & Other Post Retirement Benefits	41.8M	31.6M	24.4M	19.4M	21M
Deferred Tax Liability Non Current	342M	322M	158M	86M	54.1M
Other Non Current Liabilities	753M	756M	779M	886M	890M
Total Liabilities	7.53B	7.77B	7.49B	7.14B	7.59B
Common Stock, Total	18.6M	18.6M	18.6M	18.6M	18.6M
Additional Paid In Capital	880M	909M	936M	966M	972M
Retained Earnings	4.99B	5.56B	6.59B	6.64B	4.17B
Treasury Stock	-2.54B	-2.65B	-2.72B	-2.72B	-2.72B
Comprehensive Income and Other	-316M	-460M	-406M	-411M	-369M
Total Common Equity	3.03B	3.38B	4.41B	4.49B	2.07B
Minority Interest	19.4M	23M	22.5M	21.3M	27.4M
Total Equity	3.05B	3.4B	4.43B	4.51B	2.1B
Total Liabilities And Equity	10.58B	11.17B	11.93B	11.65B	9.69B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	126M	125M	125M	125M	125M
ECS Total Common Shares Outstanding	126M	125M	125M	125M	125M
Book Value / Share	24.12	27	35.35	35.95	16.58
Tangible Book Value	-1.1B	-852M	229M	508M	-385M
Tangible Book Value Per Share	-8.72	-6.81	1.83	4.07	-3.08
Total Debt	3.34B	3.42B	4.11B	3.5B	4.2B
Net Debt	2.82B	2.84B	3.8B	3.14B	3.61B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-18M	200K	-9.1M	-13.1M	-8.9M
Debt Equivalent Oper. Leases	309M	314M	372M	390M	356M
Minority Interest, Total (Incl. Fin. Div)	19.4M	23M	22.5M	21.3M	27.4M
Account Code - Inventory Valuation	4	5	5	5	5
LIFO Reserve, Total	-116M	-	-	-	-
Inventories - Raw Materials, Total	232M	267M	349M	220M	184M
Inventories - Work In Process, Total	731M	807M	732M	549M	553M
Inventories - Finished Goods, Total	559M	578M	644M	434M	483M
Land - (BS)	104M	104M	98.1M	96.3M	91M
Buildings, Total	528M	523M	540M	537M	578M
Machinery, Total	551M	613M	717M	758M	867M
Full Time Employees	6.4K	6.6K	6.6K	5.7K	5.5K
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	37.4M	33.9M	29.1M	39.4M	43.3M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	736M	736M	1.32B	341M	-2.24B
Depreciation & Amortization - CF	108M	109M	120M	111M	101M
Amortization of Goodwill and Intangible Assets - (CF)	62.7M	60.6M	64.3M	65.5M	73M
Depreciation & Amortization, Total	171M	169M	184M	176M	174M
Asset Writedown & Restructuring Costs	108M	93.1M	212M	220M	1.96B
(Income) Loss On Equity Investments - (CF)	-	-	-	-	-
Stock-Based Compensation (CF)	17.8M	24.2M	25.9M	23.8M	24M
Tax Benefit from Stock Options	-	-	-	-	-
Net Cash From Discontinued Operations	-78.5M	-77.6M	-86.1M	-65.6M	-74M
Other Operating Activities, Total	100M	62M	-1.17B	-258M	677M
Change In Accounts Receivable	-241M	-444M	192M	-349M	228M
Change In Inventories	-331M	-182M	-72.8M	476M	-156M
Change In Accounts Payable	144M	165M	-626M	172M	20.1M
Change in Unearned Revenues	284M	52.1M	-199M	-26.5M	-1.8M
Change In Income Taxes	-90.3M	19.1M	-62.8M	-5.4M	-186M
Change in Other Net Operating Assets	-400K	-35.5M	-102M	-33.1M	-506M
Cash from Operations	820M	582M	-386M	671M	-80.2M
Capital Expenditure	-100M	-142M	-134M	-67.9M	-96.3M
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-5.2M	-198M	-16.5M	-4.8M	-2.5M
Divestitures	-	-	-	340M	-12.1M
Sale (Purchase) of Real Estate properties	-	50.5M	5.8M	-	-
Sale (Purchase) of Intangible assets	-31.5M	6.8M	2.9M	2.7M	-
Other Investing Activities, Total	24.8M	16.8M	-12.7M	-6.4M	11.2M
Cash from Investing	-112M	-266M	-154M	264M	-99.7M
Short Term Debt Issued, Total	105M	115M	401M	-	460M
Long-Term Debt Issued, Total	1B	-	1.5B	-	750M
Total Debt Issued	1.1B	115M	1.9B	-	1.21B
Short Term Debt Repaid, Total	-	-	-	-577M	-
Long-Term Debt Repaid, Total	-1.2B	-1.4M	-1.2B	-	-501M
Total Debt Repaid	-1.2B	-1.4M	-1.2B	-577M	-501M
Issuance of Common Stock	7.9M	9.4M	5.3M	200K	200K
Repurchase of Common Stock	-408M	-109M	-81.2M	-2.3M	-1.8M
Common Dividends Paid	-247M	-268M	-290M	-291M	-291M
Common & Preferred Stock Dividends Paid	-247M	-268M	-290M	-291M	-291M
Other Financing Activities, Total	-2.4M	15.8M	-1.4M	-700K	-30M
Cash from Financing	-748M	-237M	332M	-870M	386M
Foreign Exchange Rate Adjustments	-12.3M	-23.4M	-60.3M	-9.7M	21.1M
Net Change in Cash	-52.1M	55.2M	-270M	54.9M	227M
Supplemental Items
Cash Interest Paid	126M	144M	230M	232M	242M
Cash Income Tax Paid (Refund)	139M	122M	180M	156M	196M
Levered Free Cash Flow	676M	596M	-428M	841M	94.78M
Unlevered Free Cash Flow	758M	691M	-279M	989M	245M
Change In Net Working Capital	19.6M	140M	783M	-457M	6.9M
Net Debt Issued / Repaid	-98.2M	114M	699M	-577M	709M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	6.94	7.08	3.68	3.37	1.41
Return on Total Capital	11.25	11.63	5.53	4.8	2.1
Return On Equity %	26.58	25.63	36.24	9.02	-66.61
Return on Common Equity	26.79	25.59	36.39	9.03	-67.19
Margin Analysis
Gross Profit Margin %	43.04	40.1	40.81	38.83	33.81
SG&A Margin	14.15	13.36	16.37	15.18	19
EBITDA Margin %	26.25	24.25	19.25	19.11	11.93
EBITA Margin %	24.1	22.37	16.57	16.5	9.03
EBIT Margin %	22.86	21.33	15.14	14.96	6.93
Income From Continuing Operations Margin %	15.9	14.45	31.64	9.5	-63.47
Net Income Margin %	14.6	12.69	29.45	8.03	-64.57
Net Avail. For Common Margin %	15.91	14.34	31.59	9.46	-63.55
Normalized Net Income Margin	12.71	11.61	5.12	5.87	-0.03
Levered Free Cash Flow Margin	13.41	10.28	-9.53	19.81	2.73
Unlevered Free Cash Flow Margin	15.03	11.92	-6.23	23.28	7.05
Asset Turnover
Asset Turnover	0.49	0.53	0.39	0.36	0.32
Fixed Assets Turnover	5.39	6.03	4.51	4.3	3.91
Receivables Turnover (Average Receivables)	2.05	2.13	1.61	1.51	1.4
Inventory Turnover (Average Inventory)	2.3	2.19	1.57	1.78	1.9
Short Term Liquidity
Current Ratio	1.4	1.43	1.52	1.64	1.32
Quick Ratio	0.95	0.96	0.96	1.17	0.79
Operating Cash Flow to Current Liabilities	0.23	0.15	-0.11	0.22	-0.02
Days Sales Outstanding (Average Receivables)	177.75	171.58	226.75	241.63	261.33
Days Outstanding Inventory (Average Inventory)	158.86	166.64	232	206.18	192.53
Average Days Payable Outstanding	119.33	120.84	124.03	120.95	121.46
Cash Conversion Cycle (Average Days)	217.28	217.38	334.72	326.86	332.4
Long Term Solvency
Total Debt/Equity	109.31	100.7	92.6	77.54	200.05
Total Debt / Total Capital	52.22	50.17	48.08	43.67	66.67
LT Debt/Equity	94.1	84.15	70.98	69.51	136.61
Long-Term Debt / Total Capital	44.96	41.93	36.85	39.15	45.53
Total Liabilities / Total Assets	71.16	69.56	62.83	61.31	78.33
EBIT / Interest Expense	8.8	8.15	2.86	2.69	1
EBITDA / Interest Expense	10.4	9.53	3.84	3.65	1.91
(EBITDA - Capex) / Interest Expense	9.63	8.59	3.27	3.36	1.51
Total Debt / EBITDA	2.45	2.37	4.51	4.06	9.16
Net Debt / EBITDA	2.07	1.96	4.18	3.65	7.89
Total Debt / (EBITDA - Capex)	2.64	2.63	5.29	4.41	11.6
Net Debt / (EBITDA - Capex)	2.23	2.18	4.9	3.96	9.98
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	8.68	15.01	-22.67	-5.36	-18.34
Gross Profit, 1 Yr. Growth %	5.83	7.66	-21.31	-9.95	-28.9
EBITDA, 1 Yr. Growth %	5.9	7.08	-38.62	-6.03	-49
EBITA, 1 Yr. Growth %	5.78	7.66	-42.72	-5.77	-55.3
EBIT, 1 Yr. Growth %	6.03	8.27	-45.11	-6.49	-62.18
Earnings From Cont. Operations, 1 Yr. Growth %	38.57	4.15	69.25	-71.58	-645.56
Net Income, 1 Yr. Growth %	33.54	-0.42	79.43	-74.19	-756.38
Normalized Net Income, 1 Yr. Growth %	9.41	6.08	-65.89	8.41	-100.45
Diluted EPS Before Extra, 1 Yr. Growth %	40.32	5.21	71.94	-71.62	-648.42
Accounts Receivable, 1 Yr. Growth %	10.87	11.14	-5.86	7.4	-28.98
Inventory, 1 Yr. Growth %	28.3	8.52	4.42	-30.33	1.5
Net Property, Plant and Equip., 1 Yr. Growth %	3.61	2.23	4.2	-5.34	-15.39
Total Assets, 1 Yr. Growth %	3.88	4.67	6.76	-2.29	-16.87
Tangible Book Value, 1 Yr. Growth %	-15.02	-15.15	-126.85	121.8	-175.85
Common Equity, 1 Yr. Growth %	2.39	8.12	30.58	1.74	-53.84
Cash From Operations, 1 Yr. Growth %	26.6	-28.98	-166.35	-273.68	-111.95
Capital Expenditures, 1 Yr. Growth %	-24.62	42.16	-5.9	-49.29	41.83
Levered Free Cash Flow, 1 Yr. Growth %	35.56	0.88	-171.69	-296.72	-88.7
Unlevered Free Cash Flow, 1 Yr. Growth %	27.77	2.7	-140.41	-453.84	-75.2
Dividend Per Share, 1 Yr. Growth %	9.44	10.15	6.91	0	-21.55
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	4.62	11.8	-5.7	-14.45	-12.09
Gross Profit, 2 Yr. CAGR %	2.09	6.62	-7.96	-15.82	-19.98
EBITDA, 2 Yr. CAGR %	4.16	6.3	-16.78	-24.05	-30.77
EBITA, 2 Yr. CAGR %	3.6	6.5	-19.2	-26.53	-35.1
EBIT, 2 Yr. CAGR %	3.8	6.92	-20.55	-28.36	-40.53
Earnings From Cont. Operations, 2 Yr. CAGR %	21.49	20.27	32.77	-30.65	24.52
Net Income, 2 Yr. CAGR %	24.21	15.47	33.67	-31.95	30.16
Normalized Net Income, 2 Yr. CAGR %	6.34	7.49	-37.76	-39.19	-93.62
Diluted EPS Before Extra, 2 Yr. CAGR %	23.27	21.66	34.5	-30.14	24.76
Accounts Receivable, 2 Yr. CAGR %	7.61	11	2.29	0.55	-12.66
Inventory, 2 Yr. CAGR %	17.57	22.78	6.45	-14.7	-15.91
Net Property, Plant and Equip., 2 Yr. CAGR %	1.59	2.92	3.21	-0.69	-10.51
Total Assets, 2 Yr. CAGR %	3.53	4.72	5.71	2.13	-9.87
Tangible Book Value, 2 Yr. CAGR %	-19.24	-18.72	-52.27	-22.83	29.71
Common Equity, 2 Yr. CAGR %	9.43	6.79	18.82	15.26	-31.47
Cash From Operations, 2 Yr. CAGR %	29.57	-5.18	-31.36	7.35	-54.44
Capital Expenditures, 2 Yr. CAGR %	3.25	3.52	15.66	-30.92	-15.19
Levered Free Cash Flow, 2 Yr. CAGR %	-3.75	6.04	-11.78	18.76	-53.08
Unlevered Free Cash Flow, 2 Yr. CAGR %	-4.44	5.18	-33.48	19.58	-6.93
Dividend Per Share, 2 Yr. CAGR %	9.6	9.8	8.52	3.4	-11.43
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	5.59	7.97	-1.13	-5.59	-15.77
Gross Profit, 3 Yr. CAGR %	3.67	3.75	-3.64	-8.63	-20.43
EBITDA, 3 Yr. CAGR %	6.66	4.85	-11.48	-13.34	-33.5
EBITA, 3 Yr. CAGR %	6.01	4.64	-13.39	-14.95	-37.74
EBIT, 3 Yr. CAGR %	6.36	4.95	-14.39	-16.12	-42.1
Earnings From Cont. Operations, 3 Yr. CAGR %	14.27	15.56	34.78	-20.58	37.93
Net Income, 3 Yr. CAGR %	13.62	15.55	33.74	-22.74	44.86
Normalized Net Income, 3 Yr. CAGR %	8.18	5.9	-26.68	-25.11	-88.14
Diluted EPS Before Extra, 3 Yr. CAGR %	17.08	17	36.53	-19.92	38.92
Accounts Receivable, 3 Yr. CAGR %	6.42	8.77	5.07	3.96	-10.45
Inventory, 3 Yr. CAGR %	11.08	17.54	16.33	-7.57	-9.61
Net Property, Plant and Equip., 3 Yr. CAGR %	7.95	1.8	3.34	0.28	-5.85
Total Assets, 3 Yr. CAGR %	1.99	4.21	5.4	2.97	-4.64
Tangible Book Value, 3 Yr. CAGR %	-0.47	-20.26	-43.81	-20.35	-23.27
Common Equity, 3 Yr. CAGR %	-0.96	10.08	14.2	12.83	-15.04
Cash From Operations, 3 Yr. CAGR %	30.57	6.04	-15.82	-6.47	-48.36
Capital Expenditures, 3 Yr. CAGR %	6.44	14.86	0.28	-12.14	-12.2
Levered Free Cash Flow, 3 Yr. CAGR %	16.45	-6.52	-6.93	15.26	-45.84
Unlevered Free Cash Flow, 3 Yr. CAGR %	13.96	-5.92	-23.54	16.12	-29.28
Dividend Per Share, 3 Yr. CAGR %	29.84	9.78	8.83	5.6	-5.69
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	14.72	18.05	0.92	-1.63	-5.67
Gross Profit, 5 Yr. CAGR %	18.45	19.07	-1.25	-4.57	-10.55
EBITDA, 5 Yr. CAGR %	22.22	24	-4.58	-7.84	-19.77
EBITA, 5 Yr. CAGR %	24.37	25.99	-6.14	-9.17	-22.83
EBIT, 5 Yr. CAGR %	24.54	26.49	-6.66	-9.91	-26
Earnings From Cont. Operations, 5 Yr. CAGR %	43.75	44.51	21.43	-5.79	30.58
Net Income, 5 Yr. CAGR %	28.64	6.57	21.35	-6.5	32.3
Normalized Net Income, 5 Yr. CAGR %	26.37	29.23	-14.63	-15.18	-71.35
Diluted EPS Before Extra, 5 Yr. CAGR %	45.55	45.39	23.8	-4.81	31.74
Accounts Receivable, 5 Yr. CAGR %	8.83	7.04	4.75	5.41	-2.42
Inventory, 5 Yr. CAGR %	24.03	10.72	10.96	3.39	2.17
Net Property, Plant and Equip., 5 Yr. CAGR %	12.09	-1.03	6.03	0.8	-2.44
Total Assets, 5 Yr. CAGR %	11.5	3.94	3.64	3.37	-1
Tangible Book Value, 5 Yr. CAGR %	9.16	-6.22	-27.11	-21.3	-21.48
Common Equity, 5 Yr. CAGR %	9.15	4.72	7.16	12.12	-6.9
Cash From Operations, 5 Yr. CAGR %	10.5	11.66	0.96	6.56	-34.15
Capital Expenditures, 5 Yr. CAGR %	1.88	30.02	10.04	-6.28	-6.23
Levered Free Cash Flow, 5 Yr. CAGR %	14.6	10.78	-0.03	2.87	-29.14
Unlevered Free Cash Flow, 5 Yr. CAGR %	14.71	11.15	-11.42	3.55	-17.11
Dividend Per Share, 5 Yr. CAGR %	24.45	26.88	20.85	7.18	0.22